Medical Health & Life Science Research News

Latest estrogen receptor research report just published

Medical Market Research

Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Estrogen receptor alpha (ERA) is a nuclear receptor that is activated by the sex hormone estrogen. It is encoded by the gene ESR1.

It is involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis.

Access Report : www.themarketreports.com/report/es…e-review-h1-2018

This report enables readers to

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand the targeted therapy areas and indications for Estrogen Receptor
  • Identify the use of drugs for target identification and drug repurposing
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Estrogen Receptor development landscape

Access report at: www.themarketreports.com/report/buy-now/1022562

Companies Mentioned

  • Arvinas Inc
  • AstraZeneca Plc
  • Atossa Genetics Inc
  • Eagle Pharmaceuticals Inc
  • Endece LLC
  • EndoCeutics Inc
  • H3 Biomedicine Inc
  • Mithra Pharmaceuticals SA
  • Novartis AG
  • Nuevolution AB
  • Shenogen Pharma Group Ltd

Make enquiries at: www.themarketreports.com/report/as…ur-query/1022562

News From

The Market Reports - Industry & Market Reports at its BESTThe Market Reports
Category: Market Research Publishers and RetailersCompany about: The Market Reports aims to provide the best industry and market reports to a seeker. We are looking forward to a place where we are the one stop destination for all the report seekers irrespective of any country, category, domain, etc. We are always open on call and email (24*7) to your queries and very clean with the business methodology. Since we are dealing with so many Publishers, we can actually give you what suits best in accordance to your requirements.
This email address is being protected from spambots. You need JavaScript enabled to view it.